Eight-year follow-up of patients with immune thrombocytopenic purpura related to H. pyloriinfection

Platelets

Volumn 22, Issue 1, 2011, Pages 59-62

  Kikuchi, Taku ^a   Kobayashi, Takeshi ^a   Yamashita, Takuya ^a   Ohashi, Kazuteru ^a   Sakamaki, Hisashi ^a   Akiyama, Hideki ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

H. pylori; ITP

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR; STEROID; ANTIINFECTIVE AGENT; UREA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; JAPAN; MALE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; TREATMENT RESPONSE; UREA BREATH TEST; BREATH ANALYSIS; HELICOBACTER PYLORI; ISOTOPE LABELING; MIDDLE AGED; REMISSION; TREATMENT OUTCOME;

HELICOBACTER PYLORI;

ANTI-BACTERIAL AGENTS; BREATH TESTS; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ISOTOPE LABELING; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION; TOKYO; TREATMENT OUTCOME; UREA;

EID: 78651519413     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.515272     Document Type: Article

References (9)

1. Garbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878.
2. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provqan D, Newland A, Amadori S, Bussl JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: A systematic review. Blood 2009;113:1231-1240.
3. Arnold DM, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y, Kelton JG, Growther MA. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: A systematic review. Haematologica 2009;94:850-856.
4. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-186.
5. Emillia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, Volzone F, Jovic G, Leonard G, Donelli A, et al. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: Long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007;110:3833-3841.
6. Tsumoto C, Tominaga K, Okazaki H, Tanigawa T, Yamagami H, Watanabe K, Nakao T, Koh K, Watanabe T, Fujiwara Y, et al. Long-term efficacy of Heliocobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study. Ann Hematol 2009;88:789-793.
7. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, Teramura M, Koda K, Nomura S, Sugiura S, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005;81:162-168.
8. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009;113:2386-2393.
9. Archimandritis A, Balatsos V, Delis V, Manika Z, Skandalis N. Reappearance of Helicobacter pylori after eradication: Implications on duodenal ulcer recurrence: A prospective 6 year study. J Clin Gastroenterol 1999;28:345-347.